Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
0% found this document useful (0 votes)
8 views14 pages

Chapter 8

Download as pdf or txt
Download as pdf or txt
Download as pdf or txt
You are on page 1/ 14

Dr.

Elie Salem Sokhn, PhD

1
Introduction
 The organisms that belong to the genus Mycobacterium are
 Aerobic
 Although some may grow in reduced oxygen concentrations
 Non–spore forming
 Non-motile
 Very thin
 Slightly curved or straight rods.

 Mycobacterium spp. have an unusual cell wall structure.


 The cell wall contains N-glycolylmuramic acid instead of N-
acetylmuramic acid, and it has a very high lipid content,
which creates a hydrophobic permeability barrier.
 Mycobacteria are difficult to stain
2
Cont’d
 Relatively slow growth (two groups)
 Rapid growers (Visible colonies in <7 days)
 Slow growers (Visible colonies in > 7 days)

 Mycobacteria can be divided into two major groups,


based on fundamental differences in epidemiology
and association with disease:
 Those belonging to the M. tuberculosis complex and the
NTM group.

3
Mycobacterium tuberculosis
Complex
 The mycobacterial species that occur in humans and
belong to the M. tuberculosis complex include:
 M. tuberculosis
 Mycobacterium bovis
 Mycobacterium africanum
 Mycobacterium caprae
 Mycobacterium microti
 Etc…

 All of these species are capable of causing tuberculosis.

 The organisms that belong to the M. tuberculosis complex


are considered slow growers, and colonies are
nonpigmented.
4
Cont’d
 M. tuberculosis is the cause of most cases of human
tuberculosis, particularly in developed countries.

 Inhalation of a single viable organism has been shown to


lead to infection, although close contact is usually
necessary.

 After ingestion of milk from infected cows, M. bovis may


penetrate the gastrointestinal mucosa or invade the
lymphatic tissue of the oropharynx.

 An attenuated strain of M. bovis, bacillus Calmette-Guérin


(BCG), has been used extensively in many parts of the
world to immunize susceptible individuals against
tuberculosis.
5
Cont’d
 Tuberculosis may mimic other diseases, such as
pneumonia, neoplasm, or fungal infections.

 Clinical manifestations in patients infected with M.


tuberculosis complex may range from asymptomatic to
acutely symptomatic.

 Patients who are symptomatic can have systemic


symptoms, pulmonary signs and symptoms, signs and
symptoms related to other organ involvement (e.g., the
kidneys), or a combination of these features.
6
Laboratory Diagnosis of
Mycobacterial Infections
 Specimens received by the laboratory for mycobacterial
smear and culture must be handled in a safe manner.

 Acid-fast bacilli can infect almost any tissue or organ of the


body.

 Successful isolation of these organisms depends on the


quality of the specimen obtained and the use of
appropriate processing and culture techniques by the
mycobacteriology laboratory.

 Most specimens are respiratory samples


7
Cont’d
 Processing to recover acid-fast bacilli from clinical
specimens involves several complex steps, each of
which must be carried out with precision.

 Specimens from sterile sites can be inoculated directly


to media (small volume) or concentrated to reduce
volume.
 Other specimens require decontamination and
concentration.

8
Mycobacterium tuberculosis colonies on Lowenstein-Jensen
agar after 8 weeks of incubation.

Cont’d

9
Cont’d
 Acid-Fast Stains
 The cell walls of mycobacteria contain long-chain,
multiple cross-linked fatty acids, called mycolic acids.
 Mycolic acids contribute to the characteristic of acid-
fastness that distinguishes mycobacteria from other
bacteria.
 Visualization of acid-fast bacilli in sputum or other
clinical material should be considered presumptive
evidence of tuberculosis.

10
Cont’d
 Fuchsin Acid-Fast Stains.
 The classic carbolfuchsin stain (Ziehl-Neelsen) requires
heating of the slide for better penetration of the stain
into the mycobacterial cell wall
 Hence, it is also known as the hot stain procedure.
 With Ziehl-Neelsen staining, Mycobacterium spp.
appear red or have a red-blue, beaded appearance,
whereas nonmycobacteria appear blue.

11
Cont’d

12
Treatment
 Drug-resistant tuberculosis is a major health threat

 More than 500,000 cases of multidrug-resistant (MDR)


tuberculosis occur each year.

 MDR tuberculosis is resistant to rifampin and isoniazid,


the two drugs most often used as effective treatment
against tuberculosis.

 Strains of extensively drug-resistant tuberculosis (XDR TB)


are emerging that are resistant not only to rifampin and
isoniazid, but also to quinolones and other drugs, such as
aminoglycosides.
13
Cont’d
 To prevent the selection of resistant mutants,
treatment of tuberculosis requires four drugs:
 Isoniazid

 Rifampin

 Ethambutol

 Pyrazinamide

14

You might also like